PRI · Primerica, Inc.
$278.49
+4.06 (+1.48%)
At close · Oct 26
Return incl. dividend (before tax)
Market Cap
$8.45B
Shares
30.78M
Volume · Oct 26
72.73K
Avg daily vol (3M)
185.29K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$274.43
Open$283.47
Day$273.75–284.26
52W close$245.55–326.41
Avg vol 30d196K
Short int1.4M · 4.5% float · 6.0d
Short vol65%
Last earningsAug 6, 2026
DataJan 2020–Oct 2026
Filing10-Q · Aug 6
Up next
Next earnings call
Nov 5, 2026
Est · unconfirmed
· in 1 wks
filed Aug 6, 2026
call held Aug 6, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$3.43B
Trailing 12 months
Net income (TTM)
$796.21M
Trailing 12 months
Revenue growth YoY
+9.0%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
11.0
Trailing earnings · reciprocal yield 9.1%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
1.7%
Trailing 12 months
Shares change YoY
-5.1%
Year over year · fewer shares
Price change (1Y)
+3.6%
Trailing year
Short interest
4.5%
Latest settlement · 6.0 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q2 FY26 earnings call · Aug 6, 2026
Q2 FY26
TL;DR. Primerica reported Q2 2026 with strong ISP growth (revenues +21%, pre-tax income +31%; client assets hit a record $140 billion) driving adjusted EPS up 17% to $6.41 and ROAE up 90 bps to 33.1%, while Term Life policies issued fell 12% and the life-licensed sales force declined 3% year-over-year.
Bullish
- + Investment and Savings Products delivered record sales of $4.4 billion, up 23% year-over-year, with pre-tax income up 31%
- + Client asset values reached a record $140 billion, up 16%, driven by $397 million of net inflows and favorable markets
- + Adjusted operating EPS grew 17% to $6.41 and adjusted ROAE rose 90 bps to 33.1%, reflecting a high-quality, fee-like earnings mix
- + Term Life adjusted direct premiums grew 3.4% with a stable 21.3% operating margin, providing consistent earnings
- + Capital return to stockholders remained robust at $172 million in Q2 ($135 million repurchases + $37 million dividends) with a $1.20 declared dividend
Bearish
- − Term Life policies issued declined 12% and estimated annualized issued premium fell 9%, with guidance for full-year 2026 policies issued to decline mid-single digits
- − Life-licensed sales force fell 3% to 148,612 and new life-licensed representatives dropped 15%, lagging the recent improvement in recruiting
- − Term Life insurance expense ratio rose to 8.4% from 7.6% and consolidated expenses grew 8%, with expense growth guided to 10-12% in Q3
- − Investment portfolio carried a $140 million net unrealized loss, though attributed to interest-rate movements rather than credit
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Neutral
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Low
Market backdrop
VIX 19.5 · elevated
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−1%
below
Price vs 50-day avg
−4%
below
RSI (14)
39
neutral
MACD trend
Positive
52-week position
36%
mid-range
Momentum
relative strength
1-month return
0%
trailing
6-month return
+1%
trailing
YTD return
+6%
this year
Relative strength
−4%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $287 › 200d $278 — 50d above 200d
Institutional flow
Accumulating
106 of 530 funds reported for Sep 30 · net +18.3K sh shares · +14 new
Insider flow
Distributing
Net -$87.5K over 90 days · 100% sells
Short interest
Rising
4.50% of float · ▲ +14.8% MoM · 6.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
530 holders — near 3-yr high, broad support
Squeeze score
60
elevated · 0–100
Fundamentals
Revenue growth
+7%
Y/Y
EPS growth
+67%
Y/Y
Free cash flow
$897.3M
Valuation
P/E 11
below peers
Buyback
$204.8M
remaining
Balance sheet
$262.2M
net debt
Quant / Vol
risk profile
Volatility
21%
annualized · 1-yr
Max drawdown
−17%
past year
ATR
2.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Aug 6, 2026
full-year 2026
ISP sales
10% – 15%
Adjusted direct premiums
Non-GAAP
3.5%
Benefits and claims ratio
58%
DAC amortization and commissions ratio
12% – 13%
Operating margin
Non-GAAP
21%
Expense growth
7% – 8%
fourth quarter 2026
Effective tax rate
22%
Expense growth
6% – 7%
Prior guidance
period ended
· from the Earnings Call filed Aug 6, 2026
Expense growth
· third quarter 2026
10% – 12%
Effective tax rate
· third quarter 2026
23%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−1%
Neutral
Price vs 50-day avg
−4%
Neutral
RSI (14)
39
Neutral
MACD trend
Positive
Bullish
52-week position
36%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $287 › 200d $278 — 50d above 200d
Institutional flow
Accumulating
106 of 530 funds reported for Sep 30 · net +18.3K sh shares · +14 new
Insider flow
Distributing
Net -$87.5K over 90 days · 100% sells
Short interest
Rising
4.50% of float · ▲ +14.8% MoM · 6.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
530 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $246
Now $274 · 36%
Range high $326
vs 200-day avg -1%
vs 50-day avg -4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Asset values, beginning of period | 126.76B | Three months ended June 30, 2026 filing | — |
| Asset values, end of period | $140.04B | the three months ended June 30, 2026 filing | — |
| Average monthly rate of new policies issued per life-licensed independent sales representative | 0.18 | Three months ended June 30, 2026 filing | — |
| Average number of life-licensed independent sales representatives | 149,200 | Three months ended June 30, 2026 filing | — |
| Face amount in-force, beginning of period | 965.67B | Three months ended June 30, 2026 filing | — |
| Terminations | -23.65B | Three months ended June 30, 2026 filing | — |
| Total average client asset values | $135.55B | the three months ended June 30, 2026 filing | — |
| Total sales-based revenue generating product sales | 3.14B | Three months ended June 30, 2026 filing | — |
| Account-based variable margin per average fee generating position | $3.97 | Q2 2026 | — |
| Adjusted direct premiums non-GAAP | 696.84M | Q2 2026 | — |
GAAP → non-GAAP reconciliationGAAP Direct premiums 873.6M
-176.77M Premiums ceded to IPO coinsurers
= Adjusted direct premiums 696.84M
|
|||
| Adjusted net operating income non-GAAP | $201M | Q2 2026 | — |
| Adjusted operating income before income taxes non-GAAP | $256.53M | Q2 2026 | — |
| Adjusted stockholders' equity non-GAAP | 2.44B | June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Stockholders' equity 2.52B
+110.64M Net unrealized gains (losses)
-190.8M Effect of change in discount rate assumptions on the liability for future policy benefits
= Adjusted stockholders' equity 2.44B
|
|||
| Asset-based variable margin as % of average asset values | 0.06% | Q2 2026 | — |
| Average Client Asset Values | 135.5B | Q2 2026 | — |
| Benefits and claims ratio | 57.9% | Q2 2026 | — |
| Capital returned to stockholders | 172M | Q2 2026 | — |
| Client asset net inflows | $397M | Q2 2026 | — |
| Client asset values | 140B | Q2 2026 | — |
| Closed U.S. Mortgage Volume | $150.6M | Q2 2026 | — |
| Common stock repurchases | 135M | Q2 2026 | — |
| DAC amortization and insurance commissions ratio | 12.3% | Q2 2026 | — |
| Diluted adjusted operating EPS non-GAAP | $6.41 | Q2 2026 | — |
| Dividend per share | $1.2 | Q2 2026 | — |
| Dividends paid | 37M | Q2 2026 | — |
| Effective income tax rate | 21.7% | Q2 2026 | — |
| Estimated annualized issued premium | $89.9M | Q2 2026 | — |
| Estimated average annualized issued term life premium per policy | $891 | Q2 2026 | — |
| Insurance expense ratio | 8.4% | Q2 2026 | — |
| Investment & Savings average client asset values | $135,550 | Q2 2026 | — |
| Investment & Savings product sales | $4.36B | Q2 2026 | — |
| ISP Product Sales | 4.4B | Q2 2026 | — |
| Issued Term Life Face Amount | 27.7B | Q2 2026 | — |
| Life Insurance Policies Issued | 78,904 | Q2 2026 | — |
| Life Productivity | 0.18 | Q2 2026 | — |
| Life-insurance licensed sales force, end of period | 149,732 | Q2 2026 | — |
| Life-Licensed Sales Force | 148,612 | Q2 2026 | — |
| New Life-Licensed Representatives | 11,020 | Q2 2026 | — |
| Number of new policies issued | 78,904 | Q2 2026 | — |
| Pre-tax adjusted operating income non-GAAP | 3.8M | Q2 2026 | — |
| Primerica Life Insurance Company's estimated statutory risk-based capital ratio | 440% | Q2 2026 | — |
| Recruits | 82,346 | Q2 2026 | — |
| Sales-based variable margin as % of revenue-generating sales | 1.26% | Q2 2026 | — |
| Term life face amount in-force, end of period | 967.91B | Q2 2026 | — |
| Term Life segment operating margin | 21.3% | Q2 2026 | — |
| Total average client assets | 135.55B | Q2 2026 | — |
| Total average number of fee-generating positions | 3.42M | Q2 2026 | — |
| Year-to-date capital returned to stockholders | 352M | YTD 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance - Life — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PRI
this stock
Primerica, Inc.
|
$8.45B | +6.2% | +6.6% | 11.0 | 4.5% |
|
CILJF
China Life Insurance Co Ltd
|
$83.38B | -14.5% | — | — | 0.0% |
|
MFC
Manulife Financial Corp
|
$73.22B | +22.0% | — | — | 0.7% |
|
MET
Metlife Inc
|
$62.80B | +25.2% | +8.6% | 18.9 | 1.8% |
|
AFL
Aflac Inc
|
$60.42B | +9.3% | -9.3% | 13.0 | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PRI | -2.9% | -0.4% | +1.4% | +0.8% | +6.2% |
| SPY | -0.4% | -1.5% | +5.8% | -0.4% | +11.5% |
| vs SPY | -2.5% | +1.1% | -4.4% | +1.1% | -5.2% |
Capital returns
Latest dividend
$1.20
/ share · ex Aug 21, 2026
Paid (TTM)
$4.64
/ share · 4 payouts
Dividend yield (TTM, derived)
1.69%
Buyback program
· as of Jun 30, 2026
Authorized
$475.00M
Spent (derived)
$270.20M
Remaining
$204.80M
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1475922
CUSIP
74164M108
13F (30d)
105 filings
104 filers
Visit website
Investor relations